연구
교육
솔루션
로그인
KR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Clinical Center of Biotherapy at Zhongshan Hospital
Yunyu Mao has not added Biography.
If you are Yunyu Mao and would like to personalize this page please email our Author Liaison for assistance.
Current status and future development of anti-HIV chimeric antigen receptor T-cell therapy.
Immunotherapy Feb, 2021 | Pubmed ID: 33225803
Engineering T cells with hypoxia-inducible chimeric antigen receptor (HiCAR) for selective tumor killing.
Biomarker research Oct, 2020 | Pubmed ID: 33292642
PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivo.
Biomarker research Nov, 2020 | Pubmed ID: 33292688
Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study.
Cell discovery May, 2024 | Pubmed ID: 38740803
Fudan University
Ying Xue*,1,
Yunyu Mao*,2,
Qibin Liao3,
Chen Zhao4,
Xiaoyan Zhang1,2,4,
Jianqing Xu1,2,4
1Institutes of Biomedical Sciences, Fudan University,
2Clinical Center of Biotherapy at Zhongshan Hospital, Fudan University,
3Department of Oncology and Bio-therapeutic Center, Shenzhen Third People's Hospital, Southern University of Science and Technology,
4Shanghai Public Health Clinical Center, Fudan University
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
교수 리소스 센터
저자
사서
액세스
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유
